Home › Trial NCT03397238
Myeloid Cell Reprogramming in Thyroid Carcinoma
- Trial IDNCT03397238
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorRadboud University Medical Center
- Enrollment41
- Start date2018-03-06
- ConditionsThyroid Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.